UMIN-CTR

UMIN-CTR is the clinical trials Registry run by the university Hospital Medical Information Network (UMIN) in Japan. It provIDEs a public-facing Database of registered CLInical studies together with a submission system used by investigators at univeRSIties, hospitals, and research institutions. The registry is primarily a records and transparency service rather than a Generative AI product, so readers looking for model-driven tooling should treat it as a research infORMation resource.

What it does

The platform lets research teams register trial protocols and then publishes structured summaries that the public can browse and search. Each record typically covers the study's purpose, design, eligibility criteria, interventions, recruitment status, and responsible institution. This supports transparency, helps avoid unnecessary duplication of studies, and gives patients, clinicians, and journalists a way to find ongoing or completed research in Japan.

Key capabilities

• Public search: query registry entries by keywords, condition, intervention, sponsor, and recruitment status.
• Trial registration: Investigators subMIT protocol detAIls through an online form and receive a registration identifier.
• Record updates: Registered teams can revise status and results information as a study progresses.
• Bilingual interface: Japanese and English entry points are available, which helps international readers locate studies conducted in Japan.
• Institutional scope: The registry is oriented toward academic and hospital-based research rather than commercial product marketing.

Who it is for

The registry serves several audiences. Academic investigators and hospital research offices use it to satisfy journal and funder registration expectations. Patients and caregivers consult it when exploring treatment options or seeking studies relevant to a condition. Journal editors anD systematic review authors rely on registry entries to check reporting completeness. Regulatory and ethics reviewers may also reference records when assessing research transparency.

How to get started

Visitors can open the public search page and enter a disease name, drug, or institution to see matching records; no account is needed for browsing. Research teams that need to register a study Generally must follow the site's submission process, which may involve an institutional representative and specific formatting requirements. Because procedures and eligibility rules can change, confirm current requirements on the official site before submitting.

Pricing and access caveat

Public browsing and searching of registry records are generally free of charge, and the service is accessible over the open web without a VPN in most cases. Registration Workflows may require institutional authorization rather than Personal payment, but the exACT conditions, submission fees if any, and account policies may vary and should be verified directly with UMIN. This overview reflects the general nature of clinical trial registries and does not assert specific version numbers, developer details beyond UMIN's Operation, or pricing commitments.